• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Perspectives in asthma: molecular use of microbial products in asthma prevention and treatment.

作者信息

Racila Doina M, Kline Joel N

机构信息

Division of Pulmonary, Critical Care and Occupational Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, IA 52242, USA.

出版信息

J Allergy Clin Immunol. 2005 Dec;116(6):1202-5. doi: 10.1016/j.jaci.2005.08.050. Epub 2005 Oct 24.

DOI:10.1016/j.jaci.2005.08.050
PMID:16337446
Abstract

Asthma and atopy are characterized by T(H)2-type patterns of inflammation. The hygiene hypothesis suggests that early-life environmental exposure to microbes, other pathogens, and their products promotes innate immune responses that suppress atopy; the current epidemic of allergic disease may result from a dearth of such stimuli. Antiatopic responses engendered by these exposures include both T(H)1-type and regulatory-type patterns, the latter including mechanisms of antigen-presenting cells as well as those of lymphoid origin, and are characterized by prominent IL-10 and/or TGF-beta effects. The Toll-like receptors are an important family of innate immune response elements that have many similar structural and functional properties, but have evolved to recognize distinct ligands as well as to be expressed differentially on immune cells. An active and productive area of current research is investigating the utility of microbes and microbial products for modulation of inflammation in asthma and atopic disorders. Clinical trials have been conducted for some of these biologic compounds, such as cytosine-guanine dinucleotide DNA and Mycobacterium vaccae, whereas others remain in preclinical testing.

摘要

相似文献

1
Perspectives in asthma: molecular use of microbial products in asthma prevention and treatment.
J Allergy Clin Immunol. 2005 Dec;116(6):1202-5. doi: 10.1016/j.jaci.2005.08.050. Epub 2005 Oct 24.
2
CpG DNA and immunotherapy of allergic airway diseases.
Clin Exp Allergy. 2003 Oct;33(10):1330-5. doi: 10.1046/j.1365-2222.2003.01763.x.
3
Use of CpG oligonucleotides in treatment of asthma and allergic disease.CpG寡核苷酸在哮喘和过敏性疾病治疗中的应用。
Adv Drug Deliv Rev. 2009 Mar 28;61(3):256-62. doi: 10.1016/j.addr.2008.12.007. Epub 2009 Jan 9.
4
Eat dirt: CpG DNA and immunomodulation of asthma.接触有害物质:CpG DNA与哮喘的免疫调节
Proc Am Thorac Soc. 2007 Jul;4(3):283-8. doi: 10.1513/pats.200701-019AW.
5
Toll-like receptors--novel targets in allergic airway disease (probiotics, friends and relatives).
Eur J Pharmacol. 2006 Mar 8;533(1-3):308-18. doi: 10.1016/j.ejphar.2005.12.062. Epub 2006 Jan 24.
6
Development of an asthma vaccine: research into BCG.哮喘疫苗的研发:卡介苗研究
Drugs. 2000 Jun;59(6):1217-21. doi: 10.2165/00003495-200059060-00002.
7
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.
8
Mimicking microbial 'education' of the immune system: a strategy to revert the epidemic trend of atopy and allergic asthma?模仿免疫系统的微生物“训练”:一种扭转特应性和过敏性哮喘流行趋势的策略?
Respir Res. 2000;1(3):129-32. doi: 10.1186/rr22. Epub 2000 Oct 25.
9
CpG oligodeoxynucleotides in asthma.哮喘中的CpG寡脱氧核苷酸
Curr Opin Investig Drugs. 2001 Jul;2(7):914-8.
10
The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.免疫刺激性CpG寡脱氧核苷酸的免疫生物学及临床潜力
J Leukoc Biol. 2000 Oct;68(4):455-63.

引用本文的文献

1
Exacerbation of pulmonary infection by comorbid allergic asthma is associated with diminished mycobacterium-specific Th17 responses.合并变应性哮喘的肺部感染恶化与分枝杆菌特异性 Th17 反应减弱有关。
Virulence. 2021 Dec;12(1):2546-2561. doi: 10.1080/21505594.2021.1979812.
2
Lipid A: Immunological Properties and Molecular Basis of Its Binding to the Myeloid Differentiation Protein-2/Toll-Like Receptor 4 Complex.脂质 A:免疫特性及其与髓样分化蛋白-2/ toll 样受体 4 复合物结合的分子基础。
Front Immunol. 2018 Aug 14;9:1888. doi: 10.3389/fimmu.2018.01888. eCollection 2018.
3
The effect of natural adjuvants on pathological changes in sensitized Guinea pig lungs.
天然佐剂对致敏豚鼠肺部病理变化的影响。
Iran Red Crescent Med J. 2014 Feb;16(2):e14267. doi: 10.5812/ircmj.14267. Epub 2014 Feb 7.
4
Single systemic administration of Ag85B of mycobacteria DNA inhibits allergic airway inflammation in a mouse model of asthma.单次给予分枝杆菌 DNA 的 Ag85B 可抑制哮喘小鼠模型中的过敏性气道炎症。
J Asthma Allergy. 2012;5:71-9. doi: 10.2147/JAA.S37667. Epub 2012 Dec 3.
5
The microbiome of the lung.肺部微生物组。
Transl Res. 2012 Oct;160(4):258-66. doi: 10.1016/j.trsl.2012.02.005. Epub 2012 Feb 28.
6
Primary prevention of allergic diseases: current concepts and mechanisms.过敏性疾病的一级预防:当前的概念和机制。
Allergy Asthma Clin Immunol. 2007 Dec 15;3(4):105-13. doi: 10.1186/1710-1492-3-4-105.
7
Modulation of allergic airway inflammation by the oral pathogen Porphyromonas gingivalis.口腔病原体牙龈卟啉单胞菌对过敏性气道炎症的调节作用。
Infect Immun. 2010 Jun;78(6):2488-96. doi: 10.1128/IAI.01270-09. Epub 2010 Mar 22.
8
Intestinal bacteria and the regulation of immune cell homeostasis.肠道细菌与免疫细胞稳态的调节。
Annu Rev Immunol. 2010;28:623-67. doi: 10.1146/annurev-immunol-030409-101330.
9
Overview of the immune response.免疫反应概述。
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S3-23. doi: 10.1016/j.jaci.2009.12.980.
10
Intranasal CpG therapy attenuated experimental fungal asthma in a TLR9-dependent and -independent manner.经鼻 CpG 疗法以 TLR9 依赖和非依赖的方式减轻实验性真菌性哮喘。
Int Arch Allergy Immunol. 2010;152(2):98-112. doi: 10.1159/000265531. Epub 2009 Dec 16.